Skip to main content
ChemoPrescribe LLC.
  • HOME
  • ABOUT
  • SIGN IN
  • SIGN UP

Other Pages – Top Ad

Oncoprescribe-SI

Advertisement

⟰ 🠈

Term: stable disease

Pronunciation: (STAY-bul dih-ZEEZ)

May 24, 2024October 7, 2025

Description:

Cancer that is neither decreasing nor increasing in extent or severity.

Related Posts:

  • FDA Approves ENDARI® for Sickle Cell Disease
  • FDA Approves ENJAYMO® for Cold Agglutinin Disease
  • Oncoprescribe Blog Malignant Melanoma – An Elusive Disease?
  • FDA Approves ENDARI®, A New Treatment for Sickle…
  • FDA Approves DOPTELET® for Thrombocytopenia in…
  • FDA Approves ADAKVEO®, A New Targeted Therapy for…

Post navigation

ST1481
stage

Other Pages – Bottom Ad

hem-onc-updates

Advertisement

Subscribe

FREE SUBSCRIPTION
  • ABOUT
  • PRIVACY
  • TERMS
  • DISCLAIMER
  • CONTACT
ChemoPrescribe LLC. All Rights Reserved

Leaving ChemoPrescribe

You are now leaving ChemoPrescribe website.

To return to the website, click on the back arrow on your browser.